about

We offer the latest timely and accurate Testosterone articles covering all commonly available forms of Testosterone.

If you are considering purchasing Testosterone then let us give you the facts you need!

Delatestryl

March 2010
SunMonTueWedThuFriSat
 123456
78910111213
14151617181920
21222324252627
28293031 

Please select a testosterone article from the list below:

Wednesday 27th of June 2007

M2 Presswire - Morning Alert for Indevus Pharmaceuticals Inc.

Wednesday 27th of June 2007, 4:59 pm

June 27, 2007 -- M2 PRESSWIRE-27 June 2007-Biotech News: Morning Alert for Indevus Pharmaceuticals Inc(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:27062007...

Thursday 7th of June 2007

M2 Presswire - Current Research on Indevus Pharmaceuticals Inc.

Thursday 7th of June 2007, 4:59 pm

June 7, 2007 -- M2 PRESSWIRE-7 June 2007-Biotech News: Current Research on Indevus Pharmaceuticals Inc(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:07062007...

Monday 26th of March 2007

M2 Presswire - Indevus Pharmaceuticals Inc is Added to the Bellwether Watch list.

Monday 26th of March 2007, 4:59 pm

March 26, 2007 -- M2 PRESSWIRE-26 March 2007-Biotech News: Indevus Pharmaceuticals Inc is Added to the Bellwether Watch list(C)1994-2007 M2 COMMUNICATIONS LTD...

Friday 2nd of March 2007

M2 Presswire - Analysis of Indevus Pharmaceuticals Inc.

Friday 2nd of March 2007, 3:59 pm

March 2, 2007 -- M2 PRESSWIRE-2 March 2007-Biotech News: Analysis of Indevus Pharmaceuticals Inc(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:02032007 Analysis of...

Tuesday 12th of December 2006

M2 Presswire - Fundamental Review for Indevus Pharmaceuticals Inc.

Tuesday 12th of December 2006, 3:59 pm

December 12, 2006 -- M2 PRESSWIRE-12 December 2006-Biotech News: Fundamental Review for Indevus Pharmaceuticals Inc(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:12122006...

Monday 9th of January 2006

Business Wire - Savient Pharmaceuticals Closes Sale of Delatestryl® Product to Indevus Pharmaceuticals

Monday 9th of January 2006, 3:59 pm

January 9, 2006 -- Savient Pharmaceuticals Closes Sale of Delatestryl(R) Product to Indevus Pharmaceuticals. EAST BRUNSWICK, N.J. -- Savient Pharmaceuticals, Inc....

Business Wire - Indevus Announces Closing of Delatestryl® Transaction

Monday 9th of January 2006, 3:59 pm

January 9, 2006 -- LEXINGTON, Mass. -- Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) today announced the closing of the previously announced acquisition of the U.S....

Tuesday 13th of December 2005

Business Wire - Savient Pharmaceuticals Agrees to Sale of Delatestryl® to Indevus Pharmaceuticals

Tuesday 13th of December 2005, 3:59 pm

December 13, 2005 -- EAST BRUNSWICK, N.J. -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNTE) an emerging specialty pharmaceuticals company focused on developing,...

Business Wire - Indevus Pharmaceuticals Announces Fiscal 2005 Year End and Fourth Quarter Results; Company Acquires Rights to Delatestryl®; Company Finalizes NDA Submission Plans for NEBIDO®

Tuesday 13th of December 2005, 3:59 pm

December 13, 2005 -- LEXINGTON, Mass. -- Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) today announced its consolidated results of operations for the fiscal year and the...

Monday 8th of September 2003

Business Wire - Savient Pharmaceuticals, Inc. Announces FDA Approval of New Manufacturing Site for Delatestryl, Savient's Injectable Testosterone Product

Monday 8th of September 2003, 4:59 pm

September 8, 2003 -- Business Editors/Health/Medical Writers Business Editors/Health/Medical Writers BIOWIRE2K EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Sept. 8,...





Powered by Odin Assemble